The increasing incidence of chronic kidney disease, the availability of advanced dialysis, machines disposables and replacement fluids, and increasing government initiatives to increase the accessibility of dialysis treatment and growing adoption home hemodialysis are expected to drive market growth in the coming years.
The global Hemodialysis
Market is projected to reach USD
105.1 billion by 2026 from USD 76.9
billion in 2021, at a CAGR of 6.4% during the forecast period.
Key Market Dynamics
1
DRIVERS
1
Increasing number of ESRD patients
2 Growing prevalence
of diabetes and
hypertension
3 Shortage of organ
donors and risks associated with kidney transplants
4
Technological advancements and product launches
2
RESTRAINTS
1
Risks and complications of dialysis
2
Reimbursement concerns in emerging markets
3
OPPORTUNITIES
1
Emerging markets
2 The increasing number of dialysis centers
3
Growing preference for home hemodialysis treatment
4
CHALLENGES
1
Benefits of renal transplantation
2
Sustainability of small and medium-sized companies in a highly competitive
market
3
Product recalls
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Market Segmentation: -
The increasing demand for dialysis product
among chronic kidney patients, increase focus of players in establishing
independent dialysis centers, and growing preference of patients to opt for
treatment in in-center dialysis are some of the factors likely to boost the
growth of the segment.
The increasing demand for invisible braces
among adults due to large adult population base with AKI, increase in
prevalence of ESRD, growing awareness about the benefits associated with home
peritoneal dialysis, and the growing adoption of dialysis products among ESRD
patients.
Significant rise in number of dialysis service provider, coupled
with the growing prevalence of ESRD. Along with this growing focus of dialysis
service providers towards expansion of their services offerings by launching
and acquiring new dialysis centers across the globe is likely to contribute
towards the growth of the segment.
Regional Analysis: -
Geographically, the emerging Asian countries, such as China, India, Japan and Singapore,
are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to
grow at the highest CAGR of 8.8% from 2021 to 2026. Expansion of healthcare
infrastructure and increase in disposable personal income, increase patient
population with acute kidney disease, diabetes, hypertension are factors likely
to support the growth of hemodialysis and peritoneal dialysis market in the
region.
Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279
Recent Developments:
·
In 2021, Mar Cor (Cantel Medical Corporation)
announced the launch of its innovative EON Portable hemodialysis Water System
·
In 2020, Fresenius Medical Care AG & Co. KGaA
announced the launch of a PVC-free peritoneal dialysis solution bag designed
for dialysis therapy performed at home.
·
In 2020, Baxter International Inc. received FDA
approval for De Novo application for Theranova dilayzers designed to deliver
expanded hemodialysis (HDx) therapy.
Market Growth and Impact:
The combined opportunities within the
hemodialysis and peritoneal dialysis market reflect a broader trend towards
patient-centered kidney care. As the healthcare industry shifts towards
value-based care models, investments in kidney health can yield substantial
returns not only financially but also in terms of improved patient outcomes,
reduced healthcare costs, and enhanced overall wellbeing.
Top Key Players: -
Prominent players in this Hemodialysis Market are Baxter
International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan),
B. Braun Melsungen AG (Germany), Asahi Kasei
Corporation (Japan), Toray Medical Co., Ltd. (Japan), among others.
Conclusion: -
Investing in kidney health by recognizing the opportunities within the
hemodialysis and peritoneal dialysis market is not only a financially sound
decision but also a chance to contribute to a healthier and more fulfilling
life for millions of individuals. By supporting technological advancements,
patient-centric approaches, and innovative care models, investors can play a
pivotal role in shaping the future of kidney health and renal care.
